ViiV Healthcare Mock Interview

Practice 30 ViiV Healthcare interview questions covering HIV innovation, patient advocacy, and specialized pharmaceutical expertise.

Question 12 of 30

Are you familiar with the CCR5-32 mutation and its possible role in preventing or curing HIV?

  • How to Answer

  • Example Answer

  • Example Answer 2

  • Community Answers

Rachelle Enns
Rachelle Enns

Rachelle Enns is an interview coach and job search expert. She works with candidates to perform their best in employment, medical, and post-secondary admission interviews.

CCR5-32 mutation is a rare genetic mutation that affects whether the receptor CCR5 is present in cells. CCR5 is the receptor used by HIV to gain entry into target cells. People who inherit the CCR5-32 mutation from one parent have reduced levels of the CCR5 receptor on their cells. People who inherit the CCR5?32 mutation from both parents completely lack the CCR5 receptor. In the case of Anthony Brown, also known as 'the Berlin patient,' Mr. Brown had life-threatening cancer and went through a very risk stem cell transplant procedure. The donor of the cells was known as a CCR5-32 homozygote (both of his parents lacked the CCR5 receptor). In Brown's case, his newly transplanted immune system lacks CCR5 receptors and is resistant to most strains of HIV. Knowledge of this receptor and the mutation has given HIV researchers increased hope of finding a way to cure HIV. Share any knowledge you have and don't forget, it's OK to ask questions.

Unlock All 30 ViiV Healthcare Questions

Prepare for questions about HIV-focused care and therapeutic leadership that ViiV interviewers expect.

Get Started